TRAITEMENT DU CARCINOME HEPATOCELLULAIRE CARACTERISE PAR UNE INFECTION PAR LE VIRUS DE L'HEPATITE B

• 收藏
• 分享

专利权人:

CELGENE CORPORATION

发明人:

FILVAROFF, ELLEN,HEGE, KRISTEN M.,LI, SHAOYI

申请号：

CA3067585

公开号：

CA3067585A1

申请日:

2018.06.21

申请国别(地区):

CA

年份:

2018

代理人:

摘要：

Provided herein are methods for treating and/or preventing hepatocellular carcinoma (HCC) characterized by hepatitis B virus (HBV) infection in a patient, comprising administering an effective amount of 7-(6-(2-hydroxypropan-2-y1)pyridin-3-y1)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one or a pharmaceutically acceptable salt or tautomer thereof (collectively referred to herein as "Compound 1") to the patient having HCC characterized by HBV infection.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/